Premium
Laboratory and epidemiologic assessment of a recent influenza B outbreak
Author(s) -
King James C.,
Haugh Connor J.,
Dupont William D.,
Thompson Juliette M.,
Wright Peter F.,
Edwards Kathryn M.
Publication year - 1988
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.1890250313
Subject(s) - outbreak , serology , virology , titer , neuraminidase , medicine , influenzavirus b , throat , virus , immunology , orthomyxoviridae , influenza a virus , antibody , anatomy
A viral surveillance system in Nashville detected an outbreak of influenza B that occurred between January and March 1986. Paired sera from 32 individuals with culture‐documented influenza B illness were tested using three serologic assays. Enzyme‐linked immunosorbent assay (ELISA) using purified hemagglutinin‐neuraminidase and plaque neutralization detected a seroresponse in 69% and 66% of these individuals, respectively. These assays were superior to hemagglutination inhibition, which detected a 41% seroresponse. ELISA was preferred because of cost and ease of performance. A group of 286 individuals, aged 1–65 years, was studied more extensively including serologic assessment before and after the influenza B outbreak. Historical information and viral throat cultures were obtained from those with influenza‐like illness during the epidemic. An influenza B infection rate (seroresponse and/or positive culture) of 31% and illness rate (infection with flu‐like symptoms during the epidemic period) of 13% was demonstrated using these methods. Pre‐epidemic mean serum ELISA IgG titers were lower in those with, versus those without, evidence of subsequent influenza B illness (1,541 vs. 4,311, P = .0026). Children ≤ 15 years of age were infected more frequently than adults (44% vs. 28%, P = .04). Fever ≥ 101°F was reported more frequently with influenza B than non‐B illness (43% vs. 18%, P = .03). These data are useful in preparing for future epidemiologic studies of influenza B and demonstrate the value of and need for standardization of ELISA as a serologic assay for influenza B.